Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
Macromolecular Rapid Communications · 2025
DOI: 10.1002/marc.202401051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Rapid Communications, 2025. Verfasst von Jiachan Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Proteolysis, Drug Delivery Systems, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 169 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Targeted protein degradation (TPD) using the proteolysis‐targeting chimeras (PROTACs) is emerging as a revolutionary technology, offering a potential strategy for cancer treatment by inducing the degradation of overexpressed oncogenic proteins in tumors. PROTACs function by recruiting E3 ligases and utilizing the ubiquitin‐proteasome pathway (UPS) to catalyze the degradation of target oncogenic proteins. Compared to traditional small molecules inhibitors, PROTACs exhibit enhanced selectivity, the ability to overcome drug resistance, and target proteins traditionally deemed “undruggable”. However, the poor water solubility and low cellular permeability of PROTACs significantly limit their pharmacokinetic properties, while potential systemic toxicity may hinder their clinical application. To address these limitations, strategies that integrate PROTACs with drug delivery systems are gaining attention. This review summarizes the latest advancements in various delivery strategies to enhance the in vivo degradation efficacy and reduce off‐target effects of PROTACs, including the prototype delivery of PROTACs using nanoparticles, covalent modification‐based prodrug strategies, innovative multi‐headed PROTACs designs, and microneedle delivery systems, while discussing their design principles and associated challenges. The combination of potent PROTACs with multifunctional delivery systems holds promise for accelerating clinical translation and improving therapeutic efficacy in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China.
- School of Chemistry and Chemical Engineering, Xi'an University of Science and Technology, Xi'an, 710054, China.
- College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Frontiers Science Center for New Organic Matter, Collaborative Innovation…
ORCID-Profile: Hongzhong Chen, Dong-Sheng Guo
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Lin, J., Chen, Z., Zhang, D., Zhang, N., Chen, H., & Guo, D. S. (2025). Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202401051
Vancouver
Lin J, Chen Z, Zhang D, Zhang N, Chen H, Guo DS. Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation. Macromolecular Rapid Communications. 2025. doi:10.1002/marc.202401051
BibTeX
@article{Lin2025,
author = {Lin, Jiachan and Chen, Zirui and Zhang, Dan and Zhang, Nan and Chen, Hongzhong and Guo, Dong-Sheng},
title = {Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation},
journal = {Macromolecular Rapid Communications},
year = {2025},
doi = {10.1002/marc.202401051}
}
EUVIMED